Claudia Sacchetto, Laura Peretto, Francisco Baralle, Iva Maestri, Francesca Tassi, Francesco Bernardi, . . . Dario Balestra. (2021). OTC intron 4 variations mediate pathogenic splicing patterns caused by the c.386G>A mutation in humans and spfash mice, and govern susceptibility to RNA-based therapies. BMC.
Chicago Style (17th ed.) CitationClaudia Sacchetto, et al. OTC Intron 4 Variations Mediate Pathogenic Splicing Patterns Caused by the C.386G>A Mutation in Humans and Spfash Mice, and Govern Susceptibility to RNA-based Therapies. BMC, 2021.
MLA (9th ed.) CitationClaudia Sacchetto, et al. OTC Intron 4 Variations Mediate Pathogenic Splicing Patterns Caused by the C.386G>A Mutation in Humans and Spfash Mice, and Govern Susceptibility to RNA-based Therapies. BMC, 2021.